Saurashtra News

Blood Culture Tests Demand Driven By Increasing Prevalence Of Bloodstream Infections And Infectious Diseases | Market Growing At A CAGR Of 9.1% | Grand View Research, Inc.

 Breaking News
  • No posts were found

Blood Culture Tests Demand Driven By Increasing Prevalence Of Bloodstream Infections And Infectious Diseases | Market Growing At A CAGR Of 9.1% | Grand View Research, Inc.

August 02
13:08 2021
Blood Culture Tests Demand Driven By Increasing Prevalence Of Bloodstream Infections And Infectious Diseases | Market Growing At A CAGR Of 9.1% | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to a new report published by Grand View Research, Growing approval rate of new products, such as instruments and consumables for Bloodstream Infections (BSI) diagnosis, by regulatory authorities is a major factor contributing to the growth.

The global blood culture test market size is expected to reach USD 7.3 billion, at a CAGR of 9.1% by 2026, according to a new report by Grand View Research, Inc. Increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the growth. Rising demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is projected to drive the growth. Thus, many manufacturing companies have begun focusing on development of advanced diagnostic instruments and consumables. For instance, Cepheid offers Xpert MRSA/SA assay that aids in accurate detection of SA and MRSA in positive blood culture specimens in about an hour.

Introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests. According to the Centers for Disease Control and Prevention (CDC), there was 46% decrease in central line-associated bloodstream infections in U.S. between 2008 and 2013, owing to the efforts taken by the U.S. government for the prevention of Hospital-acquired Infections (HAIs). 

Blood Culture Tests Market Report Highlights

 Conventional blood culture technique was the largest revenue-grossing segment in 2018 owing to increased applications of this method in hospitals, independent clinical laboratories, and pathology laboratories

In product segment, consumables accounted for the largest market share in terms of revenue in 2018, due the product applications in diagnostics and research, with repetitive purchase, such as blood culture media, assay, kits, and reagents, adding to the revenue

Automated blood culture systems is the fastest growing segment owing to the advantages of automation, such as low chances of error and faster result generation

Molecular technology is projected to expand at the highest CAGR over the forecast period, due to rising demand for advanced products by hospitals and laboratories for diagnosis of infectious diseases

Bacterial infections accounted for the largest revenue share in 2018, due to the fact that they are the most common cause for infection in the blood

Reference laboratories is projected to expand at the highest CAGR during the study period, because there is an increase in outsourcing of blood tests by hospitals to reference laboratories

North America accounted for the largest revenue share of the blood culture test market in 2018, due to the presence of well-developed healthcare infrastructure in this region

Asia Pacific is anticipated to register the highest CAGR during the forecast period owing to increased focus of government on the prevention of infectious diseases.

Few key players include Becton, Dickinson and Company; bioMérieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche; Bruker Corporation; and Abbott Laboratories.

For Requesting a Sample Copy Please Visit @ https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market/request/rs15

Blood Culture Tests Market Segmentation

Grand View Research has segmented the global blood culture tests market on the basis of product, technique, technology, application, end use, and region:

Blood Culture Tests Product Outlook (Revenue, USD Million, 2015 – 2026)
    • Consumables
             • Bacterial Infections
             • Fungal Infections
             • Mycobacterial Infections
             • Blood Culture Media
                         • Aerobic
                         • Anaerobic
                         • Fungi/yeast
                         • Others
             • Assay, Kits, and Reagents
             • Blood Culture Accessories
    • Instruments
             • Bacterial Infections
             • Fungal Infections
             • Mycobacterial Infections
             • Laboratory Equipment
                         • Incubators
                         • Colony Counters
                         • Microscopes
                         • Gram Stainers
            • Automated Blood Culture Systems
    • Software & Services

             • Bacterial Infections
             • Fungal Infections
             • Mycobacterial Infections

Blood Culture Tests Technique Outlook (Revenue, USD Million, 2015 – 2026)
    • Conventional
    • Automated

Blood Culture Tests Technology Outlook (Revenue, USD Million, 2015 – 2026)
    • Culture-based Technology
    • Molecular Technology
             • PCR
             • Microarray
             • PNA-FISH
    • Proteomic Technology
Blood Culture Tests Application Outlook (Revenue, USD Million, 2015 – 2026)
    • Bacterial Infections
    • Fungal Infections
    • Mycobacterial Infections
Blood Culture Tests End-Use Outlook (Revenue, USD Million, 2015 – 2026)
    • Hospitals Laboratories
    • Reference Laboratories
    • Others

Blood Culture Tests Regional Outlook (Revenue, USD Million, 2015 – 2026)
     North America
        • The U.S.
        • Canada
    • Europe
        • Germany
        • The U.K.
        • Spain
        • Italy
        • France
        • Russia
    • Asia Pacific
        • China
        • India
        • Japan
        • Indonesia
        • Singapore
        • Thailand
        • South Korea
        • Australia
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • MEA
        • Saudi Arabia
        • South Africa

        • UAE

Fill the Pre-Order Enquiry Form for the Report @ https://www.grandviewresearch.com/inquiry/1464/ibb

 

Browse Related Reports:

Cord Blood Banking Services MarketSize & Growth Analysis Report, By Bank Types (Public, Private, Hybrid) By Region (North America, Europe, Asia Pacific, LATAM, MEA), And Segment Forecasts, 2018 – 2025.

 

Disposable Blood Pressure Cuffs MarketSize, Share & Trends Analysis Report By Call Points (Surgeons, Physician, Clinicians), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2018 – 2025.

 

About Grand View Research

Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market/